Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Initiation of ALD518/BMS-945429 Phase 2b clinical trial in RA triggers milestone payment to Alder

Initiation of ALD518/BMS-945429 Phase 2b clinical trial in RA triggers milestone payment to Alder

NASDAQ halts Regeneron's common stock

NASDAQ halts Regeneron's common stock

Positive results from etanercept pilot study against dermatomyositis

Positive results from etanercept pilot study against dermatomyositis

Economic burden of fractures in Europe has been vastly underestimated: New report

Economic burden of fractures in Europe has been vastly underestimated: New report

Humira defect lawyers file suit against Abbott Laboratories in federal court

Humira defect lawyers file suit against Abbott Laboratories in federal court

Nose spray vaccine for type 1 diabetes could be a reality soon

Nose spray vaccine for type 1 diabetes could be a reality soon

CEL-SCI initiates Multikine Phase III clinical trial for head and neck cancer in Hungary

CEL-SCI initiates Multikine Phase III clinical trial for head and neck cancer in Hungary

Scientists identify potential target for reversing deadly blood infection sepsis

Scientists identify potential target for reversing deadly blood infection sepsis

Hanwha, Merck partner to develop and commercialize HD203

Hanwha, Merck partner to develop and commercialize HD203

NYU Langone webinar discusses advances in the treatment of RA

NYU Langone webinar discusses advances in the treatment of RA

Rosa, Profil Institute partner to offer simulation technology for diabetes and obesity clinical trials

Rosa, Profil Institute partner to offer simulation technology for diabetes and obesity clinical trials

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

Study explores link between hospital procedure volume, surgical outcomes after joint replacements

Study explores link between hospital procedure volume, surgical outcomes after joint replacements

Ligand's LGD-4033 Phase I clinical trial data presented at the Endocrine Society annual meeting

Ligand's LGD-4033 Phase I clinical trial data presented at the Endocrine Society annual meeting

Bayer HealthCare seeks EU marketing authorization of VEGF Trap-Eye for treatment of wet AMD

Bayer HealthCare seeks EU marketing authorization of VEGF Trap-Eye for treatment of wet AMD

New approach for identifying 'self' proteins targeted in autoimmune diseases

New approach for identifying 'self' proteins targeted in autoimmune diseases

SQI Diagnostics reports net loss of $1,874,000 for second quarter 2011

SQI Diagnostics reports net loss of $1,874,000 for second quarter 2011

Positive data from Augurex's RA biomarker blood test, novel drug target presented at EULAR conference

Positive data from Augurex's RA biomarker blood test, novel drug target presented at EULAR conference

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

Study: Cardiovascular disease may be under treated in rheumatoid arthritis patients

Study: Cardiovascular disease may be under treated in rheumatoid arthritis patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.